CFO Bradford Amman resigns effective July 31, 2026
Vivos Therapeutics and CFO Bradford Amman signed a separation agreement on July 31, 2026, resulting in his resignation from all executive and board roles while retaining an advisory position to support a transition.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day